visit sniclinic dot com here

CASE STUDY

Class III NPN Approval for a Stress Support Formula

Case Study Overview

Project 

Details 

Client 

Established U.S. supplement brand 

Product 

Multi-ingredient stress support capsule 

Pathway 

Class III Product Licence Application 

Challenge 

Non-monograph claims and evidence gaps 

Outcome 

Product licence and NPN issued 

Timeline 

Approximately 12 months 

This fictional case study illustrates SNI’s regulatory approach and does not represent an actual client or submission. Any resemblance to real companies, products, or regulatory filings is purely coincidental and unintended.

The Regulatory Challenge

A U.S. supplement brand engaged SNI to support the Canadian launch of a stress support formula containing botanical, mineral, and amino acid ingredients.

 

Although several ingredients appeared in Health Canada monographs, the complete formula did not qualify for a Class I pathway. The proposed doses, botanical extracts, claims, and combined conditions of use required additional safety and efficacy evidence.

 

SNI also identified inconsistencies between the supplier specifications, clinical studies, product formula, and proposed Canadian label. If left unresolved, these gaps could have resulted in additional questions or refusal.



SNI’s Regulatory Approach

SNI assessed each medicinal ingredient against Health Canada’s Natural Health Products Ingredients Database (NHPID) and applicable monographs. The review considered ingredient identity, source material, extract ratio, potency, daily dose, route of administration, and risk information.

 

The proposed claims were then compared with the populations, doses, and outcomes evaluated in the supporting studies. Claims that extended beyond the available evidence were refined while preserving the product’s core stress support positioning.

 

SNI prepared the Class III PLA, safety and efficacy rationale, supporting evidence package, and Canadian label. All documents were aligned before submission to ensure the ingredient details, claims, directions, and risk statements remained consistent.


Addressing Health Canada’s Questions

During assessment, Health Canada issued an Information Request Notice (IRN) seeking clarification about one botanical extract, dose alignment, the safety of the combined formula, and a proposed claim.

SNI prepared a structured response supported by updated supplier documentation, relevant scientific evidence, revised claim wording, and strengthened risk information. The response was submitted within the required timeframe and reflected consistently across the PLA and label.



Outcome

Health Canada issued the product licence and NPN approximately 12 months after the project began. The authorized product retained meaningful stress support positioning while meeting Canadian requirements for safety, efficacy, quality, and labelling.



Key Lessons

Ingredient Monograph

Monograph-listed ingredients do not automatically qualify a product for a Class I application.

Claim Alignment

Claims should be aligned with the evidence before the PLA and label are finalized.

Supplier Documents

Supplier documentation must use consistent ingredient, extract, and potency information.

IRN Considerations

A successful IRN response must address every question without creating new discrepancies.

SNI supported the project from initial classification and evidence review through PLA preparation, label alignment, and Health Canada correspondence, giving the client a clear and defensible path to the Canadian market.

Complex NHP formulas require more than a PLA completion

Our Recent Articles:

Cosmetic Packaging Design: Where Branding and Claims Collide

November 18, 2026
Cosmetic packaging design goes beyond aesthetics. Discover how product claims, visual identity and regulatory considerations influence effective packaging, and how brands can balance creativity with compliance.

Pet Food Traceability in Canada: What Are the Requirements?

November 11, 2026
Is pet food traceability mandatory in Canada? Understand CFIA oversight, applicable regulatory requirements, voluntary industry standards, lot coding, and recall preparedness for Canadian pet food manufacturers and importers.

How to Build a Packaging Design System That Scales Across Multiple SKUs

November 4, 2026
One SKU is easy. What about 100? Learn how scalable packaging design systems keep products consistent, recognizable, and ready for growth without sacrificing creativity.
Loading...